Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece.
Neurol Ther
; 11(3): 1375-1390, 2022 Sep.
Article
in En
| MEDLINE
| ID: mdl-35829919
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Observational_studies
Language:
En
Journal:
Neurol Ther
Year:
2022
Type:
Article
Affiliation country:
Greece